Man Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-47,986
| Closed | -$1.32M | – | 2049 |
|
|
2024
Q1 | $1.32M | Sell |
47,986
-146,119
| -75% | -$4.02M | ﹤0.01% | 1340 |
|
|
2023
Q4 | $5.92M | Buy |
+194,105
| New | +$5.92M | 0.02% | 829 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1433 |
|
|
2023
Q1 | – | Sell |
-30,465
| Closed | -$1.06M | – | 2138 |
|
|
2022
Q4 | $1.06M | Buy |
30,465
+8,611
| +39% | +$300K | ﹤0.01% | 1299 |
|
|
2022
Q3 | $1.22M | Buy |
+21,854
| New | +$1.22M | 0.01% | 1202 |
|
|
2018
Q4 | – | Sell |
-32,400
| Closed | -$927K | – | 2044 |
|
|
2018
Q3 | $927K | Sell |
32,400
-65,900
| -67% | -$1.89M | ﹤0.01% | 1682 |
|
|
2018
Q2 | $2.69M | Sell |
98,300
-43,200
| -31% | -$1.18M | 0.01% | 1234 |
|
|
2018
Q1 | $2.98M | Buy |
+141,500
| New | +$2.98M | 0.01% | 1094 |
|